<DOC>
	<DOCNO>NCT00992576</DOCNO>
	<brief_summary>The purpose study establish optimal hydromorphone - naloxone ratio improve bowel function constipate pain patient .</brief_summary>
	<brief_title>Optimisation Hydromorphone - Naloxone Ratio Treatment Pain</brief_title>
	<detailed_description>Subjects suffer cancer non-cancer pain suffer constipation case aggravated opioids randomise one four ratio hydromorphone PR plus naloxone PR Hydromorphone PR plus placebo investigate whether hydromorphone/naloxone combination lead comparable analgesia , decrease constipation , investigate optimal dose ratio hydromorphone naloxone .</detailed_description>
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Hydromorphone</mesh_term>
	<mesh_term>Naloxone</mesh_term>
	<criteria>1 . Male female subject least 18 year history noncancer cancer pain require aroundtheclock opioid therapy ( 8 , 24 48 mg hydromorphone PR per day duration study ) . 2 . Subjects constipation cause aggravated opioids 3 . Subjects must willing discontinue current opioid analgesic routine , . 4. current laxative regimen 1 . Chronic intermittent pain result Fibromyalgia Rheumatoid Arthritis . 2 . Subjects presently take , take , naloxone &lt; =30 day prior start Screening Period . 3 . Subjects suffer diarrhoea . 4 . Abnormal liver kidney function .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Confirmatory</keyword>
	<keyword>Constipation</keyword>
	<keyword>Pain</keyword>
	<keyword>Hydromorphone</keyword>
	<keyword>Naloxone</keyword>
</DOC>